The 15-Minute Telehealth Visit: How to Prepare So Nothing Gets Missed

Why Preparation Matters More in Telehealth

A telehealth visit for GLP-1 prescribing typically runs 10-20 minutes. That's not a lot of time to cover your medical history, discuss medication options, review potential side effects, and develop a treatment plan. Providers who do this well are efficient, but efficiency requires you to come prepared.

In a traditional PCP visit, your doctor has your chart open on their screen — years of lab results, prior diagnoses, medication changes, and visit notes. In a telehealth consultation, especially on a new platform, you're starting from scratch. Everything the prescriber knows about you comes from what you provide.

The difference between a productive telehealth visit and a frustrating one is almost always about preparation.

Your Pre-Visit Checklist

• Current medication list — every prescription and supplement, with doses. Include anything you take regularly, even if it seems unrelated.
• Recent lab results — A1C, fasting glucose, lipid panel, metabolic panel, thyroid panel if available. Results from the last 6-12 months are ideal.
• Your actual height and weight — measured recently on a calibrated scale, not estimated.
• Blood pressure readings — if you have a home cuff, take readings on two different days and bring the numbers.
• Medical history summary — active diagnoses, surgical history, family history of thyroid cancer (MTC) or MEN 2 syndrome.
• Allergy list — medication allergies and any adverse reactions to prior medications.
• Insurance card — even for cash-pay visits, having your insurance information allows the prescriber to note it for potential prior auth submissions.
• Questions you want answered — write them down before the visit. Most people forget at least one important question when they're in the moment.

Questions Worth Asking Your Prescriber

Most patients focus on "will I qualify?" and forget to ask questions that affect their long-term success. Here are the questions experienced GLP-1 users wish they'd asked at their first visit:

"What's my titration schedule?" — Understanding the dose escalation plan from the start helps you anticipate side effects and budget for changing medication costs.

"What side effects should prompt me to call you vs. ride out?" — Nausea is expected. Persistent vomiting or severe abdominal pain is not. Knowing the difference prevents both unnecessary panic and dangerous delays.

"How do we handle the prescription if I travel?" — Travel complicates both refill timing and medication storage. Your prescriber should have a protocol for early refills and temperature-sensitive shipping.

"What happens if I need to pause treatment?" — Surgery, pregnancy planning, or financial constraints may require a treatment break. Ask about restart protocols before you need them.

"Will you coordinate with my PCP?" — If you have a primary care physician, ask whether the telehealth prescriber will send visit notes to your PCP's office. This closes the care coordination gap.

Red Flags During the Visit

Not every telehealth GLP-1 visit is equal. Here are signals that the quality of care may be compromised:

No questions about thyroid history. GLP-1s carry a boxed warning about medullary thyroid carcinoma risk. A prescriber who doesn't ask about thyroid conditions or family history of MTC/MEN 2 is skipping a critical safety screen.

No mention of eating disorder screening. GLP-1s suppress appetite, which can be dangerous for patients with a history of restrictive eating disorders. Responsible prescribers screen for this.

Immediate approval with no follow-up plan. A prescription without a follow-up visit schedule, lab monitoring plan, or mechanism to reach your prescriber with questions is a warning sign about the quality of ongoing care.

Pressure to commit to long subscription terms. Your prescriber should be focused on your medical needs, not on locking you into a billing cycle. Monthly flexibility is the standard; be cautious of platforms pushing 3-6 month prepayment as a condition of treatment.